Invention Grant
- Patent Title: Thienopyrimidinone NMDA receptor modulators and uses thereof
-
Application No.: US17458797Application Date: 2021-08-27
-
Publication No.: US11648253B2Publication Date: 2023-05-16
- Inventor: David R. Anderson , Robert A. Volkmann , Frank S. Menniti , Christopher Fanger
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: McCarter & English, LLP
- Agent Michael J. DeGrazia
- Main IPC: A61K31/519
- IPC: A61K31/519 ; C07D495/04 ; A61P25/28 ; A61P25/18 ; A61P25/24
Abstract:
Disclosed herein, in part, are heteroaromatic compounds and methods of use in treating neuropsychiatric disorders, e.g., schizophrenia and major depressive disorder. Pharmaceutical compositions and methods of making heteroaromatic compounds are provided. The compounds are contemplated to modulate the NMDA receptor.
Information query
IPC分类:
